Cardinal Healthcare recalls Jardiance (empagliflozin tablets)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
- Products
-
- Jardiance (empagliflozin tablets)
- Company
- Cardinal Healthcare
- Where it was sold
-
Nationwide USA
Nationwide
- Units affected
- 1 unit
- About this recall
- Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. NDC: 0597-0153-37